Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level903 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06054984 | TCR-T Cells in the Treatment of Advanced Pancreatic Cancer(GB3010-02) | unknown | Early Phase 1 | 18 | Ruijin HospitalOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT06080854 | AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer | unknown | Phase 2 | 108 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 12, 2023 |
| clinicaltrials |
| NCT04303403 | Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma | unknown | Phase 1 | 48 | National Cancer Centre, SingaporeOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT02184663 | Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer | unknown | N/A | 313 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT04033107 | High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | unknown | Phase 2 | 30 | Zhongnan HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06048458 | Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping(PC-TOX) | unknown | — | 75 | University College, LondonOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05271344 | Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion.(SIO3D) | unknown | N/A | 74 | Centre Hospitalier Universitaire de LiegeOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT03777462 | Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1(BRPCNCC-1) | unknown | Phase 2 | 150 | Changhai HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04373928 | Personalized Precision Diagnosis and Treatment of Pancreatic Cancer(PPDTPC) | unknown | N/A | 100 | Changhai HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04902261 | Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer | unknown | Phase 2 | 140 | Changhai HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT05783076 | SBRT Plus vNKT for Pancreatic Cancer | unknown | Phase 2 | 29 | Changhai HospitalOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT05997147 | A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma | unknown | — | 1,009 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05977777 | Contrast-enhanced Ultrasound and Pancreatic Lesions | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05703581 | Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy | unknown | — | 200 | Fudan UniversityOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05959395 | Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors | unknown | N/A | 5 | NeoTherma OncologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05957250 | [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer(PANSCAN-1) | unknown | N/A | 63 | Amsterdam UMC, location VUmcOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05955092 | Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma | unknown | — | 30 | Peking Union Medical College HospitalOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05223218 | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | unknown | — | 500 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT04803851 | Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 29 | Peking Union Medical College HospitalOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT03809247 | Microbial Diversity of Pancreatic Diseases | unknown | — | 330 | Ruijin HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05193162 | Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases | unknown | — | 800 | Ruijin HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05393986 | Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors | unknown | Phase 1 | 63 | Peking UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05754788 | Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis | unknown | — | 40 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT02745847 | Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer | unknown | N/A | 30 | Changhai HospitalOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05875753 | 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer | unknown | Early Phase 1 | 50 | Peking Union Medical College HospitalOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT03553004 | Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial(NIRA-PANC) | unknown | Phase 2 | 18 | University of Kansas Medical CenterOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT04855331 | Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC | unknown | N/A | 120 | Fudan UniversityOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05842187 | In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer(ODYSSEY) | unknown | N/A | 20 | Jianzhen Shan, MDOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05830019 | Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery | unknown | N/A | 49 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT05831488 | Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer(VERVE) | unknown | — | 35 | Royal Marsden NHS Foundation TrustOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT04164602 | The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly(NODES) | unknown | — | 2,522 | University of PecsOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05802420 | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer(MAP-01) | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05616494 | A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer | unknown | Phase 2 | 53 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05511116 | Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI(ReMeTTI) | unknown | — | 48 | Fondation Hôpital Saint-JosephOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT03886571 | U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer | unknown | — | 100 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT05660915 | A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy | unknown | N/A | 80 | The First Affiliated Hospital of University of South ChinaOTHER | 1 | Feb 24, 2023 | clinicaltrials |
| NCT05729737 | Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer | unknown | — | 100 | Peking Union Medical College HospitalOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05583201 | NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors | unknown | Early Phase 1 | 18 | jianming xuOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04605237 | Pancreatic Cancer Recurrence in the Netherlands | unknown | — | 1,750 | UMC UtrechtOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT05700110 | Porto-Venous Radiomics in Pancreatic Cancer | unknown | — | 800 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04600154 | MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients | unknown | N/A | 40 | National Taiwan University HospitalOTHER | 1 | Jan 19, 2023 | clinicaltrials |
| NCT05689138 | Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer | unknown | — | 100 | Peking Union Medical College HospitalOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT04274972 | The Microbiome of Pancreatic Cancer: "PANDEMIC" Study(PANDEMIC) | unknown | — | 20 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT05237193 | A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up | unknown | — | 400 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT05043532 | Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer | unknown | N/A | 33 | Orlando Health, Inc.OTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05679050 | Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 10, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Oct 13, 2023source: clinicaltrials